Displacement of WDR5 from Chromatin by a WIN Site Inhibitor with Picomolar Affinity

[1]  E. Olejniczak,et al.  Discovery of Potent 2-Aryl-6,7-dihydro-5 H-pyrrolo[1,2- a]imidazoles as WDR5-WIN-Site Inhibitors Using Fragment-Based Methods and Structure-Based Design. , 2018, Journal of medicinal chemistry.

[2]  E. Prochownik,et al.  Diagnostic and prognostic implications of ribosomal protein transcript expression patterns in human cancers , 2018, BMC Cancer.

[3]  Ye Zhang,et al.  Induction of the p53 Tumor Suppressor in Cancer Cells through Inhibition of Cap-Dependent Translation , 2018, Molecular and Cellular Biology.

[4]  W. Tansey,et al.  Moonlighting with WDR5: A Cellular Multitasker , 2018, Journal of clinical medicine.

[5]  J. Licht,et al.  Annual Review of Pharmacology and Toxicology Targeting Epigenetics in Cancer , 2017 .

[6]  George Thomas,et al.  Ribosome biogenesis in cancer: new players and therapeutic avenues , 2017, Nature Reviews Cancer.

[7]  Phillip G. Montgomery,et al.  Defining a Cancer Dependency Map , 2017, Cell.

[8]  Lin Qiu,et al.  PI3K/AKT-mediated upregulation of WDR5 promotes colorectal cancer metastasis by directly targeting ZNF407 , 2017, Cell Death & Disease.

[9]  Yves Pommier,et al.  A subset of platinum-containing chemotherapeutic agents kills cells by inducing ribosome biogenesis stress , 2017, Nature Medicine.

[10]  A. Russo,et al.  Ribosomal Proteins Control or Bypass p53 during Nucleolar Stress , 2017, International journal of molecular sciences.

[11]  M. Cosgrove,et al.  Targeted Disruption of the Interaction between WD-40 Repeat Protein 5 (WDR5) and Mixed Lineage Leukemia (MLL)/SET1 Family Proteins Specifically Inhibits MLL1 and SETd1A Methyltransferase Complexes* , 2016, The Journal of Biological Chemistry.

[12]  Bryan J. Venters,et al.  High-Resolution Mapping of RNA Polymerases Identifies Mechanisms of Sensitivity and Resistance to BET Inhibitors in t(8;21) AML. , 2016, Cell reports.

[13]  Parantu K. Shah,et al.  In Vivo Functional Platform Targeting Patient-Derived Xenografts Identifies WDR5-Myc Association as a Critical Determinant of Pancreatic Cancer. , 2016, Cell reports.

[14]  Y. Kawasawa,et al.  WDR5 high expression and its effect on tumorigenesis in leukemia , 2016, Oncotarget.

[15]  M. Dugas,et al.  Leukemogenic MLL-ENL Fusions Induce Alternative Chromatin States to Drive a Functionally Dichotomous Group of Target Genes. , 2016, Cell reports.

[16]  Xiaofeng Dai,et al.  WDR5 Expression Is Prognostic of Breast Cancer Outcome , 2015, PloS one.

[17]  Cheryl H. Arrowsmith,et al.  Prevalent p53 mutants co-opt chromatin pathways to drive cancer growth , 2015, Nature.

[18]  K. Kim,et al.  Assaying Cell Cycle Status Using Flow Cytometry , 2015, Current protocols in molecular biology.

[19]  G. Poda,et al.  Pharmacological targeting of the Wdr5-MLL interaction in C/EBPα N-terminal leukemia , 2015, Nature chemical biology.

[20]  E. Olejniczak,et al.  Interaction with WDR5 promotes target gene recognition and tumorigenesis by MYC. , 2015, Molecular cell.

[21]  Q. Cai,et al.  Upregulated WDR5 promotes proliferation, self-renewal and chemoresistance in bladder cancer via mediating H3K4 trimethylation , 2015, Scientific Reports.

[22]  Derek W Wright,et al.  Gateways to the FANTOM5 promoter level mammalian expression atlas , 2015, Genome Biology.

[23]  W. Huber,et al.  Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2 , 2014, Genome Biology.

[24]  B. van Steensel,et al.  Easy quantitative assessment of genome editing by sequence trace decomposition , 2014, Nucleic acids research.

[25]  P. Nordlund,et al.  The cellular thermal shift assay for evaluating drug target interactions in cells , 2014, Nature Protocols.

[26]  S. Lowe,et al.  Acquired dependence of acute myeloid leukemia on the DEAD-box RNA helicase DDX5. , 2014, Cell reports.

[27]  S. De,et al.  The ADP-ribosyltransferase PARP10/ARTD10 Interacts with Proliferating Cell Nuclear Antigen (PCNA) and Is Required for DNA Damage Tolerance* , 2014, The Journal of Biological Chemistry.

[28]  Björn Usadel,et al.  Trimmomatic: a flexible trimmer for Illumina sequence data , 2014, Bioinform..

[29]  Jeffrey A. Magee,et al.  Haematopoietic stem cells require a highly regulated protein synthesis rate , 2014, Nature.

[30]  Zhaohui S. Qin,et al.  Targeting MLL1 H3K4 methyltransferase activity in mixed-lineage leukemia. , 2014, Molecular cell.

[31]  C. Danko,et al.  Enhancer transcripts mark active estrogen receptor binding sites , 2013, Genome research.

[32]  Wei Shi,et al.  featureCounts: an efficient general purpose program for assigning sequence reads to genomic features , 2013, Bioinform..

[33]  Y. Saunthararajah,et al.  AML cells are differentially sensitive to chemotherapy treatment in a human xenograft model. , 2013, Blood.

[34]  Leighton J. Core,et al.  Precise Maps of RNA Polymerase Reveal How Promoters Direct Initiation and Pausing , 2013, Science.

[35]  Yong Zhang,et al.  Identifying ChIP-seq enrichment using MACS , 2012, Nature Protocols.

[36]  Johannes E. Schindelin,et al.  Fiji: an open-source platform for biological-image analysis , 2012, Nature Methods.

[37]  Steven L Salzberg,et al.  Fast gapped-read alignment with Bowtie 2 , 2012, Nature Methods.

[38]  A. Stegh.  Targeting the p53 signaling pathway in cancer therapy – the promises, challenges and perils , 2012, Expert opinion on therapeutic targets.

[39]  Jing Liu,et al.  Imaging protein synthesis in cells and tissues with an alkyne analog of puromycin , 2011, Proceedings of the National Academy of Sciences.

[40]  Annette S. Kim,et al.  Differential expression of ribosomal proteins in myelodysplastic syndromes , 2011, Journal of Clinical Pathology.

[41]  Kou-Juey Wu,et al.  Interplay between HDAC3 and WDR5 is essential for hypoxia-induced epithelial-mesenchymal transition. , 2011, Molecular cell.

[42]  Leighton J. Core,et al.  A Rapid, Extensive, and Transient Transcriptional Response to Estrogen Signaling in Breast Cancer Cells , 2011, Cell.

[43]  Randy J. Read,et al.  Overview of the CCP4 suite and current developments , 2011, Acta crystallographica. Section D, Biological crystallography.

[44]  Christof Fellmann,et al.  Toolkit for evaluating genes required for proliferation and survival using tetracycline-regulated RNAi , 2011, Nature Biotechnology.

[45]  Elizabeth C. Townsend,et al.  Analysis of the binding of mixed lineage leukemia 1 (MLL1) and histone 3 peptides to WD repeat domain 5 (WDR5) for the design of inhibitors of the MLL1-WDR5 interaction. , 2010, Journal of medicinal chemistry.

[46]  E. Kremmer,et al.  Chemotherapeutic Drugs Inhibit Ribosome Biogenesis at Various Levels* , 2010, The Journal of Biological Chemistry.

[47]  Cole Trapnell,et al.  Ultrafast and memory-efficient alignment of short DNA sequences to the human genome , 2009, Genome Biology.

[48]  Leighton J. Core,et al.  Nascent RNA Sequencing Reveals Widespread Pausing and Divergent Initiation at Human Promoters , 2008, Science.

[49]  M. Cosgrove,et al.  A Conserved Arginine-containing Motif Crucial for the Assembly and Enzymatic Activity of the Mixed Lineage Leukemia Protein-1 Core Complex* , 2008, Journal of Biological Chemistry.

[50]  Yi Zheng,et al.  Microenvironment determines lineage fate in a human model of MLL-AF9 leukemia. , 2008, Cancer cell.

[51]  H. Ressom,et al.  Activation of p53-Dependent Growth Suppression in Human Cells by Mutations in PTEN or PIK3CA , 2006, Molecular and Cellular Biology.

[52]  M. Halaby,et al.  The identification of an internal ribosomal entry site in the 5′-untranslated region of p53 mRNA provides a novel mechanism for the regulation of its translation following DNA damage , 2006, Oncogene.

[53]  Pablo Tamayo,et al.  Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[54]  D. Guertin,et al.  Phosphorylation and Regulation of Akt/PKB by the Rictor-mTOR Complex , 2005, Science.

[55]  Xueliang Fang,et al.  Development and optimization of a binding assay for the XIAP BIR3 domain using fluorescence polarization. , 2004, Analytical biochemistry.

[56]  Bruce Stillman,et al.  Chromatin Association of Human Origin Recognition Complex, Cdc6, and Minichromosome Maintenance Proteins during the Cell Cycle: Assembly of Prereplication Complexes in Late Mitosis , 2000, Molecular and Cellular Biology.

[57]  H. Land,et al.  Advanced mammalian gene transfer: high titre retroviral vectors with multiple drug selection markers and a complementary helper-free packaging cell line. , 1990, Nucleic acids research.

[58]  Thomas R. Gingeras,et al.  STAR: ultrafast universal RNA-seq aligner , 2013, Bioinform..

[59]  R. Stark,et al.  DiffBind : Differential binding analysis of ChIP-Seq peak data , 2012 .

[60]  Z. Otwinowski,et al.  Processing of X-ray diffraction data collected in oscillation mode. , 1997, Methods in enzymology.

[61]  Z. Otwinowski,et al.  [20] Processing of X-ray diffraction data collected in oscillation mode. , 1997, Methods in enzymology.

[62]  Randy J Read,et al.  Electronic Reprint Biological Crystallography Phenix: Building New Software for Automated Crystallographic Structure Determination Biological Crystallography Phenix: Building New Software for Automated Crystallographic Structure Determination , 2022 .